PROCTER & GAMBLE HEALTH | IPCA LABS | PROCTER & GAMBLE HEALTH/ IPCA LABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.8 | 55.4 | 62.7% | View Chart |
P/BV | x | 10.6 | 5.8 | 184.1% | View Chart |
Dividend Yield | % | 2.0 | 0.3 | 663.7% |
PROCTER & GAMBLE HEALTH IPCA LABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
IPCA LABS Mar-23 |
PROCTER & GAMBLE HEALTH/ IPCA LABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,062 | 505.3% | |
Low | Rs | 3,883 | 768 | 505.6% | |
Sales per share (Unadj.) | Rs | 740.7 | 243.0 | 304.9% | |
Earnings per share (Unadj.) | Rs | 138.2 | 19.4 | 712.9% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 29.7 | 522.4% | |
Dividends per share (Unadj.) | Rs | 95.00 | 4.00 | 2,375.0% | |
Avg Dividend yield | % | 2.1 | 0.4 | 469.9% | |
Book value per share (Unadj.) | Rs | 447.6 | 230.3 | 194.4% | |
Shares outstanding (eoy) | m | 16.60 | 253.70 | 6.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 3.8 | 165.8% | |
Avg P/E ratio | x | 33.5 | 47.2 | 70.9% | |
P/CF ratio (eoy) | x | 29.8 | 30.8 | 96.7% | |
Price / Book Value ratio | x | 10.3 | 4.0 | 260.0% | |
Dividend payout | % | 68.7 | 20.6 | 333.1% | |
Avg Mkt Cap | Rs m | 76,761 | 232,120 | 33.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 12,876 | 16.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 61,642 | 19.9% | |
Other income | Rs m | 184 | 1,518 | 12.1% | |
Total revenues | Rs m | 12,480 | 63,160 | 19.8% | |
Gross profit | Rs m | 3,247 | 9,033 | 35.9% | |
Depreciation | Rs m | 281 | 2,616 | 10.7% | |
Interest | Rs m | 8 | 482 | 1.6% | |
Profit before tax | Rs m | 3,142 | 7,453 | 42.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 2,534 | 33.4% | |
Profit after tax | Rs m | 2,295 | 4,919 | 46.6% | |
Gross profit margin | % | 26.4 | 14.7 | 180.2% | |
Effective tax rate | % | 27.0 | 34.0 | 79.3% | |
Net profit margin | % | 18.7 | 8.0 | 233.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 51,893 | 22.6% | |
Current liabilities | Rs m | 6,791 | 18,058 | 37.6% | |
Net working cap to sales | % | 40.0 | 54.9 | 72.9% | |
Current ratio | x | 1.7 | 2.9 | 60.0% | |
Inventory Days | Days | 263 | 51 | 513.0% | |
Debtors Days | Days | 343 | 6 | 5,865.0% | |
Net fixed assets | Rs m | 10,617 | 34,336 | 30.9% | |
Share capital | Rs m | 166 | 254 | 65.4% | |
"Free" reserves | Rs m | 7,265 | 58,167 | 12.5% | |
Net worth | Rs m | 7,431 | 58,420 | 12.7% | |
Long term debt | Rs m | 0 | 6,518 | 0.0% | |
Total assets | Rs m | 22,330 | 86,229 | 25.9% | |
Interest coverage | x | 409.1 | 16.5 | 2,484.3% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.7 | 77.0% | |
Return on assets | % | 10.3 | 6.3 | 164.6% | |
Return on equity | % | 30.9 | 8.4 | 366.7% | |
Return on capital | % | 42.4 | 12.2 | 346.9% | |
Exports to sales | % | 0 | 42.9 | 0.0% | |
Imports to sales | % | 13.1 | 13.3 | 98.4% | |
Exports (fob) | Rs m | NA | 26,434 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 8,178 | 19.6% | |
Fx inflow | Rs m | 1,465 | 26,434 | 5.5% | |
Fx outflow | Rs m | 1,605 | 8,178 | 19.6% | |
Net fx | Rs m | -140 | 18,257 | -0.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 8,058 | 29.3% | |
From Investments | Rs m | -215 | -7,250 | 3.0% | |
From Financial Activity | Rs m | -985 | 5,072 | -19.4% | |
Net Cashflow | Rs m | 1,160 | 5,881 | 19.7% |
Indian Promoters | % | 0.0 | 46.3 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 44.9 | 44.5% | |
FIIs | % | 6.2 | 10.5 | 59.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 53.7 | 89.7% | |
Shareholders | 56,778 | 81,165 | 70.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | IPCA Labs | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.18% | -1.59% | 0.97% |
1-Month | -0.72% | 10.40% | 2.08% |
1-Year | -0.85% | 78.90% | 55.37% |
3-Year CAGR | -8.62% | 8.00% | 15.04% |
5-Year CAGR | 5.02% | 22.18% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the IPCA Labs share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of IPCA Labs the stake stands at 46.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of IPCA Labs.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
IPCA Labs paid Rs 4.0, and its dividend payout ratio stood at 20.6%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of IPCA Labs.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.